Changed lineage composition is an early event in breast carcinogenesis

Histology and Histopathology

Volumn 28, Issue 9, 2013, Pages 1197-1204

  Hilton, Heidi N ^a   Kantimm, Silke ^a   Dinny Graham, J ^a   Clarke, Christine L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Human breast; Lineage; Preinvasive lesions

Indexed keywords

ARTICLE; BREAST TUMOR; CARCINOGENESIS; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFORMATION; EPITHELIUM; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; HUMAN; HYPERPLASIA; INTRADUCTAL CARCINOMA; METABOLISM; PATHOLOGY; PROGNOSIS; RISK FACTOR;

BREAST NEOPLASMS; CARCINOGENESIS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; MICROSCOPY, FLUORESCENCE; PROGNOSIS; RISK FACTORS;

EID: 84884358201     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Abd El-Rehim D.M., Pinder S.E., Paish C.E., Bell J., Blamey R.W., Robertson J.F., Nicholson R.I. and Ellis I.O. (2004). Expression of luminal and basal cytokeratins in human breast carcinoma. J. Pathol. 203, 661-671.
2. Adriance M.C., Inman J.L., Petersen O.W. and Bissell M.J. (2005). Myoepithelial cells: Good fences make good neighbors. Breast Cancer Res. 7, 190-197.
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R. and Polyak K. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32.
4. Allred D.C., Mohsin S.K. and Fuqua S.A. (2001). Histological and biological evolution of human premalignant breast disease. Endocr. Relat. Cancer 8, 47-61.
5. Anderson E. and Clarke R.B. (2004). Steroid receptors and cell cycle in normal mammary epithelium. J. Mammary Gland. Biol. Neoplasia 9, 3-13.
6. Arpino G., Laucirica R. and Elledge R.M. (2005). Premalignant and in situ breast disease: Biology and clinical implications. Ann. Intern. Med. 143, 446-457.
7. Barbareschi M., Pecciarini L., Cangi M.G., Macrì E., Rizzo A., Viale G. and Doglioni C. (2001). P63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am. J. Surg. Pathol. 25, 1054-1060.
8. Barsky S.H. and Karlin N.J. (2005). Myoepithelial cells: Autocrine and paracrine suppressors of breast cancer progression. J. Mammary Gland Biol. Neoplasia 10, 249-260.
9. Batistatou A., Stefanou D., Arkoumani E. and Agnantis N.J. (2003). The usefulness of p63 as a marker of breast myoepithelial cells. In vivo 17, 573-576.
10. Boulos F.I., Dupont W.D., Simpson J.F., Schuyler P.A., Sanders M.E., Freudenthal M.E. and Page D.L. (2008). Histologic associations and long-term cancer risk in columnar cell lesions of the breast. Cancer 113, 2415-2421.
11. Cichon M., Degnim A., Visscher D. and Radisky D. (2010). Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J. Mammary Gland Biol. Neoplasia 15, 389-397.
12. Clayton H., Titley I. and Vivanco M.D. (2004). Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp. Cell Res. 297, 444-460.
13. Ferguson D.J. (1985). Ultrastructural characterisation of the proliferative (stem?) cells within the parenchyma of the normal resting breast. Virchows Arch. A 407, 379-385.
14. Garbe J.C., Pepin F., Pelissier F.A., Sputova K., Fridriksdottir A.J., Guo D.E., Villadsen R., Park M., Petersen O.W., Borowsky A.D., Stampfer M.R. and LaBarge M.A. (2012). Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Res. 72, 3687-3701.
15. Gudjonsson T., Adriance M.C., Sternlicht M.D., Petersen O.W. and Bissell M.J. (2005). Myoepithelial cells: Their origin and function in breast morphogenesis and neoplasia. J. Mammary Gland Biol. Neoplasia 10, 261-272.
16. Gudjonsson T., Ronnov-Jessen L., Villadsen R., Rank F., Bissell M.J. and Petersen O.W. (2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell. Sci. 115, 39-50.
17. Gusterson B.A., Warburton M.J., Mitchell D., Ellison M., Neville A.M. and Rudland P.S. (1982). Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res. 42, 4763-4770.
18. Howard B.A. and Gusterson B.A. (2000). Human breast development. J. Mammary Gland Biol. Neoplasia 5, 119-137.
19. Joshi K., Smith J.A., Perusinghe N. and Monoghan P. (1986). Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells. Am. J. Pathol. 124, 199-206.
20. LaBarge M.A., Nelson C.M., Villadsen R., Fridriksdottir A., Ruth J.R., Stampfer M.R., Petersen O.W. and Bissell M.J. (2009). Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integrative Biol. 1, 70-79.
21. Lakhani S. and O-Hare M. (2001). The mammary myoepithelial cell cinderella or ugly sister? Breast Cancer Res. 3, 1-4.
22. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., Feleppa F., Huschtscha L.I., Thorne H.J., kConFab, Fox S.B., Yan M., French J.D., Brown M.A., Smyth G.K., Visvader J.E. and Lindeman G.J. (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913.
23. Mote P.A., Johnston J.F., Manninen T., Tuohimaa P. and Clarke C.L. (2001). Detection of progesterone receptor forms A and B by immunohistochemical analysis. J. Clin. Pathol. 54, 624-630.
24. Mote P.A., Bartow S., Tran N. and Clarke C.L. (2002). Loss of coordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res. Treat. 72, 163-172.
25. Newsham I.F. (1998). The long and short of chromosome 11 in breast cancer. Am. J. Pathol. 153, 5-9.
26. Nguyen M., Lee M.C., Wang J.L., Tomlinson J.S., Shao Z.M., Alpaugh M.L. and Barsky S.H. (2000). The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 19, 3449-3459.
27. Pandey P.R, Saidou J. and Watabe K. (2010). Role of myoepithelial cells in breast tumor progression. Front. Biosci. 15, 226-236.
28. Péchoux C., Gudjonsson T., Ronnov-Jessen L., Bissell M.J. and Petersen O.W. (1999). Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev. Biol. 206, 88-99.
29. Perusinghe N.P., Monaghan P., O-Hare M.J., Ashley S. and Gusterson B.A. (1992). Effects of growth factors on proliferation on basal and luminal cells in human breast epithelial explants in serum-free culture. In Vitro Cell. Dev. Biol. 28A, 90-96.
30. Polyak K. and Hu M. (2005). Do myoepithelial cells hold the key for breast tumor progression? J. Mammary Gland Biol. Neoplasia 10, 231-247.
31. Reis-Filho J.S. and Schmitt F.C. (2002). Taking advantage of basic research: P63 is a reliable myoepithelial and stem cell marker. Ad. Anat. Patho. 9, 280-289.
32. Rudland P.S. (1987). Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metastasis Rev. 6, 55-83.
33. Santen R.J. and Mansel R. (2005). Benign breast disorders. New Engl. J. Med. 353, 275-285.
34. Shao Z.M., Nguyen M., Alpaugh M.L., O-Connell J.T. and Barsky S.H. (1998). The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp. Cell Res. 241, 394-403.
35. Suzuki R., Atherton A.J., O'Hare M.J., Entwistle A., Lakhani S.R. and Clarke C. (2000). Proliferation and differentiation in the human breast during pregnancy. Differentiation 66, 106-115.
36. Tamimi R.M., Rosner B. and Colditz G.A. (2010). Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer 116, 4944-4953.
37. Visvader J.E. (2009). Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 23, 2563-2577.
38. Visvader J.E. (2011). Cells of origin in cancer. Nature 469, 314-322.